Close
  Indian J Med Microbiol
 

Table 1: Epi-drugs and DNA repair protein inhibitors for GBM treatment (Epi-drugs: epigenetic drugs, GBM: glioblastoma, HDAC: histone deacetylase, ATM: ataxia-telangiectasia mutated, ATR: ataxia-telangiectasia and Rad3 related, PARP: poly ADP-ribose polymerase, IDH1: isocitrate dehydrogenase 1, LSD: lysine-specific demethylase, PRKDC: protein kinase, DNA-activated, catalytic subunit, SETD8: histone H4-lysine (20) N-methyltransferase, DOT1L: disruptor of telomeric silencing 1 (It is a Histone H3-lysine (79) N-methyltransferase), EZH2: enhancer of zeste homolog 2, G9a: lysine methyltransferase which di-methylates histone H3-lysine at position 9)

Table 1: Epi-drugs and DNA repair protein inhibitors for GBM treatment (Epi-drugs: epigenetic drugs, GBM: glioblastoma, HDAC: histone deacetylase, ATM: ataxia-telangiectasia mutated, ATR: ataxia-telangiectasia and Rad3 related, PARP: poly ADP-ribose polymerase, IDH1: isocitrate dehydrogenase 1, LSD: lysine-specific demethylase, PRKDC: protein kinase, DNA-activated, catalytic subunit, SETD8: histone H4-lysine (20) N-methyltransferase, DOT1L: disruptor of telomeric silencing 1 (It is a Histone H3-lysine (79) N-methyltransferase), EZH2: enhancer of zeste homolog 2, G9a: lysine methyltransferase which di-methylates histone H3-lysine at position 9)